Skip to main content
Home
  • About
    • About the Navigator
    • Navigator FAQs
  • Guides
    • For Patients and Caregivers
    • For Physicians and Healthcare Providers
    • For Companies and Sponsors
  • Company Directory
    • View Company Directory
    • Submit Company Information
  • Resources
  • Expanded Access eRequest
  • facebook
  • twitter
  • linkedin
  • youtube
Home
  • About
    • About the Navigator
    • Navigator FAQs
  • Guides
    • For Patients and Caregivers
    • For Physicians and Healthcare Providers
    • For Companies and Sponsors
  • Company Directory
    • View Company Directory
    • Submit Company Information
  • Resources
  • Expanded Access eRequest

Recursion Pharmaceuticals, Inc.

By efain on Thu, 10/21/2021 - 11:57
  • Read more about Recursion Pharmaceuticals, Inc.

Vasgene Therapeutics, Inc.

By efain on Thu, 09/16/2021 - 16:25
  • Read more about Vasgene Therapeutics, Inc.

ISA Therapeutics B.V.

By efain on Tue, 09/14/2021 - 16:05
  • Read more about ISA Therapeutics B.V.

Cara Therapeutics

By efain on Tue, 09/14/2021 - 16:01
  • Read more about Cara Therapeutics

Compassionate Use of Concizumab if You Have Haemophilia

  • Read more about Compassionate Use of Concizumab if You Have Haemophilia

SARS-CoV-2 Vaccine (GEO-CM04S1) Versus mRNA SARS-COV-2 Vaccine in Patients With Blood Cancer

  • Read more about SARS-CoV-2 Vaccine (GEO-CM04S1) Versus mRNA SARS-COV-2 Vaccine in Patients With Blood Cancer

Efficacy of Canrenone as add-on Treatment in Moderate to Severe ARDS in COVID-19

  • Read more about Efficacy of Canrenone as add-on Treatment in Moderate to Severe ARDS in COVID-19

Clinical, Molecular and Functional Biomarkers for PROgnosis, Pathomechanisms and Treatment Strategies of COVID-19

  • Read more about Clinical, Molecular and Functional Biomarkers for PROgnosis, Pathomechanisms and Treatment Strategies of COVID-19

SOLIDARITY Finland Long-COVID (Remdesivir Long-term Follow-up Study of COVID Patients)

  • Read more about SOLIDARITY Finland Long-COVID (Remdesivir Long-term Follow-up Study of COVID Patients)

Fourth Dose of mRNA COVID-19 Vaccine in Residents of LTCFs

  • Read more about Fourth Dose of mRNA COVID-19 Vaccine in Residents of LTCFs

Pagination

  • First page « First
  • Previous page ‹ Previous
  • …
  • Page 171
  • Page 172
  • Page 173
  • Page 174
  • Current page 175
  • Page 176
  • Page 177
  • Page 178
  • Page 179
  • …
  • Next page Next ›
  • Last page Last »
Subscribe to

Subscribe for updates from the Reagan-Udall Foundation for the FDA

Subscribe
(202) 849 - 2075
1333 New Hampshire Ave, NW
Suite 420
Washington, DC 20036
navigator@reaganudall.org
  • facebook
  • twitter
  • linkedin
  • youtube

© Reagan-Udall Foundation for the FDA
© Reagan-Udall Foundation for the FDA